Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 55% ± 11% | |
lung | 19 studies | 65% ± 21% | |
intestine | 12 studies | 59% ± 20% | |
eye | 10 studies | 51% ± 21% | |
kidney | 9 studies | 64% ± 14% | |
brain | 9 studies | 34% ± 13% | |
bone marrow | 7 studies | 46% ± 23% | |
lymph node | 7 studies | 44% ± 27% | |
liver | 6 studies | 44% ± 14% | |
pancreas | 5 studies | 47% ± 13% | |
uterus | 5 studies | 75% ± 24% | |
placenta | 4 studies | 76% ± 19% | |
esophagus | 4 studies | 74% ± 16% | |
prostate | 4 studies | 66% ± 29% | |
skin | 4 studies | 64% ± 14% | |
breast | 4 studies | 66% ± 8% | |
heart | 3 studies | 40% ± 15% | |
adipose | 3 studies | 32% ± 17% | |
adrenal gland | 3 studies | 52% ± 5% | |
thymus | 3 studies | 69% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 12078.70 | 180 / 180 | 100% | 1180.04 | 429 / 430 |
thymus | 100% | 25791.90 | 653 / 653 | 100% | 1068.72 | 603 / 605 |
esophagus | 100% | 35126.29 | 1445 / 1445 | 99% | 1346.63 | 182 / 183 |
uterus | 100% | 14775.86 | 170 / 170 | 99% | 1886.41 | 455 / 459 |
intestine | 100% | 12043.63 | 966 / 966 | 98% | 1161.61 | 518 / 527 |
lung | 100% | 20069.43 | 577 / 578 | 98% | 1442.96 | 1132 / 1155 |
bladder | 100% | 16673.29 | 21 / 21 | 97% | 1354.59 | 488 / 504 |
skin | 100% | 24026.03 | 1809 / 1809 | 96% | 1349.43 | 451 / 472 |
stomach | 100% | 12118.32 | 358 / 359 | 95% | 925.08 | 273 / 286 |
brain | 98% | 6663.29 | 2590 / 2642 | 96% | 440.94 | 676 / 705 |
pancreas | 99% | 7723.87 | 324 / 328 | 93% | 1051.15 | 166 / 178 |
kidney | 100% | 17186.79 | 89 / 89 | 86% | 613.25 | 778 / 901 |
adrenal gland | 100% | 10755.21 | 258 / 258 | 74% | 288.76 | 170 / 230 |
breast | 100% | 12072.25 | 459 / 459 | 49% | 320.02 | 547 / 1118 |
prostate | 100% | 12621.43 | 245 / 245 | 27% | 100.33 | 138 / 502 |
lymph node | 0% | 0 | 0 / 0 | 100% | 1078.12 | 29 / 29 |
spleen | 100% | 10429.61 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 2384.76 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 421.18 | 1 / 1 |
adipose | 100% | 11528.24 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 15662.36 | 1329 / 1335 | 0% | 0 | 0 / 0 |
muscle | 98% | 8262.60 | 784 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 9368.13 | 831 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 1427.75 | 76 / 80 |
peripheral blood | 88% | 9640.49 | 818 / 929 | 0% | 0 | 0 / 0 |
liver | 3% | 136.88 | 6 / 226 | 12% | 100.56 | 47 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051122 | Biological process | hepoxilin biosynthetic process |
GO_0006469 | Biological process | negative regulation of protein kinase activity |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0043651 | Biological process | linoleic acid metabolic process |
GO_0098869 | Biological process | cellular oxidant detoxification |
GO_0048147 | Biological process | negative regulation of fibroblast proliferation |
GO_0070372 | Biological process | regulation of ERK1 and ERK2 cascade |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_2001237 | Biological process | negative regulation of extrinsic apoptotic signaling pathway |
GO_0071638 | Biological process | negative regulation of monocyte chemotactic protein-1 production |
GO_0002674 | Biological process | negative regulation of acute inflammatory response |
GO_0051771 | Biological process | negative regulation of nitric-oxide synthase biosynthetic process |
GO_0032691 | Biological process | negative regulation of interleukin-1 beta production |
GO_0032872 | Biological process | regulation of stress-activated MAPK cascade |
GO_0043508 | Biological process | negative regulation of JUN kinase activity |
GO_0009890 | Biological process | negative regulation of biosynthetic process |
GO_0032873 | Biological process | negative regulation of stress-activated MAPK cascade |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0070664 | Biological process | negative regulation of leukocyte proliferation |
GO_0035726 | Biological process | common myeloid progenitor cell proliferation |
GO_0006693 | Biological process | prostaglandin metabolic process |
GO_0000302 | Biological process | response to reactive oxygen species |
GO_0007417 | Biological process | central nervous system development |
GO_1901687 | Biological process | glutathione derivative biosynthetic process |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0043409 | Biological process | negative regulation of MAPK cascade |
GO_0032930 | Biological process | positive regulation of superoxide anion generation |
GO_0035732 | Biological process | nitric oxide storage |
GO_0043407 | Biological process | negative regulation of MAP kinase activity |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0010804 | Biological process | negative regulation of tumor necrosis factor-mediated signaling pathway |
GO_0043124 | Biological process | negative regulation of canonical NF-kappaB signal transduction |
GO_0006749 | Biological process | glutathione metabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005739 | Cellular component | mitochondrion |
GO_0070062 | Cellular component | extracellular exosome |
GO_0034774 | Cellular component | secretory granule lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0097057 | Cellular component | TRAF2-GSTP1 complex |
GO_0031982 | Cellular component | vesicle |
GO_0005634 | Cellular component | nucleus |
GO_0035730 | Molecular function | S-nitrosoglutathione binding |
GO_0008432 | Molecular function | JUN kinase binding |
GO_0070026 | Molecular function | nitric oxide binding |
GO_0004602 | Molecular function | glutathione peroxidase activity |
GO_0005504 | Molecular function | fatty acid binding |
GO_0004364 | Molecular function | glutathione transferase activity |
GO_0019207 | Molecular function | kinase regulator activity |
GO_0035731 | Molecular function | dinitrosyl-iron complex binding |
GO_0005515 | Molecular function | protein binding |
Gene name | GSTP1 |
Protein name | Glutathione S-transferase P (EC 2.5.1.18) (GST class-pi) (GSTP1-1) glutathione transferase (EC 2.5.1.18) (GST class-pi) Glutathione S-transferase pi Glutathione S-transferase P Glutathione S-transferase pi 1 Glutathione S-transferase (EC 2.5.1.18) (GST class-pi) Mutant GSTP1 glutathione transferase (EC 2.5.1.18) |
Synonyms | HEL-S-22 GST3 hCG_21055 FAEES3 |
Description | FUNCTION: Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Involved in the formation of glutathione conjugates of both prostaglandin A2 (PGA2) and prostaglandin J2 (PGJ2) . Participates in the formation of novel hepoxilin regioisomers . Negatively regulates CDK5 activity via p25/p35 translocation to prevent neurodegeneration. . FUNCTION: Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. . FUNCTION: Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. . FUNCTION: Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. . |
Accessions | ENST00000498765.5 ENST00000398606.10 ENST00000646888.1 P09211 V9HWE9 B2C310 A0A087X2E9 C7DJS2 A0A3B6XSH2 C7DJS1 A0A2R8Y5E5 A0A2P1FDF0 ENST00000398603.6 A8MX94 ENST00000495996.1 A0A087X243 A0A0M4UT83 A0A0M5MRY8 Q5D6A5 |